Back

Pathologic insights into tricuspid valve morphology: impact on the standard echocardiographic nomenclature

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Imaging in valvular heart disease Valvular Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Monica De Gaspari

University of Padua, Padova (Italy)

7 More presentations in this session

Presentation thumbnail
Prognostic impact of normalizing 3D mitral RegVol to LAVmax in HFrEF patients with ventricular secondary MR
Assistant Professor D. Hadareanu (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of left atrial and ventricular strain coupling after TAVR: a novel risk assessment approach
Doctor R. Wimolwattanaphan (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Incremental prognostic value of right ventricular free wall longitudinal strain in a staging classification based on cardiac damage in patients with severe aortic stenosis who underwent TAVI
Doctor K. Sato (Tsukuba, JP)
Abstract Slides Video
Presentation thumbnail
Impact of symptoms and left ventricular systolic function in patients with moderate mixed aortic valve disease
Mrs P. Lopez Santi (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Improvement of tricuspid regurgitation in patients treated with transcatheter aortic valve replacement: prognostic impact and factors associated with its regression after the intervention.
Doctor L. Milla Mendoza (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in valvular heart disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Correlations with anatomic specimens
thumbnail
Congress Presentation
Geometry of tricuspid annulus in functional tricuspid regurgitation patients: differences between aetiologies. 3D echocardiography study
thumbnail
Congress Session
3D echocardiography – anatomic specimens' correlations for valvular heart disease interventions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources